AABB Smartbrief
- Nothing great in the world has been accomplished without passion.
- FDA to review Amgen's BLA for Aimovig
- July issue of AABB News on precision medicine in transfusion medicine
- Immune Pharma weighs pro rata share distribution to fund Cytovia spinout
- Roche withdraws from deal with Oryzon Genomics for cancer drug candidate
Blood Journal
- Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination
- Predicting transformation of follicular lymphoma
- Curtis C, Mineyko A, Massicotte P, et al. Thrombophilia risk is not increased in children after perinatal stroke. Blood. 2017;129(20):2793-2800.
- NF-{kappa}B p50 (nfkb1) contributes to pathogenesis in the E{mu}-TCL1 mouse model of chronic lymphocytic leukemia
- Peripheral eosinophilia as the first manifestation of B-cell acute lymphoblastic leukemia with t(5;14)(q31;q32)
American Medical News
Error: Feed has an error or is not valid
Transfusion News
- Intrinsic Platelet Reactivity does not Affect Transfusion Outcome
- Reversal of Direct Oral Anticoagulants: a Systematic Review
- Gram-positive Bacterial Contamination of Platelets a Concern
- Demographic Changes Directly Impact Blood Supply, but Not Demand
- Study Shows Fewer Blood Donations and Transfusions in 2015
